This guidance is intended to harmonize the data recommendations associated with in vivo blood level bioequivalence (BE) for veterinary pharmaceutical products. To meet this objective, the guidance addresses the following topics:

A harmonized definition of BE.

Factors/variables that should be considered when developing scientifically sound blood level BE study designs.